Statement from Ernest J. Moniz on G-7 Leaders’ “Vision on Nuclear Disarmament”
NTI welcomes the G-7 leaders’ statement as they meet in the city where a nuclear weapon was used in war 78 years ago.
Past Event
NTI at SynBioBeta, the Global Synthetic Biology Conference
Luciana Borio, Federica Mogherini, Gustavo Zlauvinen Join NTI’s Board of Directors
The Nuclear Threat Initiative (NTI) recently added three distinguished leaders to its Board of Directors: Luciana Borio, M.D., Federica Mogherini, and Ambassador Gustavo Zlauvinen.
NTI Convenes Largest Global Dialogue on Nuclear Security Priorities Since Pandemic Began
NTI convened nuclear security leaders from across governments and industry, as well as international, research, and non-governmental organizations, for the sixteenth meeting of the Global Dialogue on Nuclear Security Priorities in Vienna, Austria.
New Report Recommends Biosecurity Safeguards for Benchtop DNA Synthesis Devices
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Article
Luciana Borio, M.D.
Luciana Borio, M.D., is a Venture Partner at ARCH Venture Partners.
Past Event
NTI Seminar: Inheriting The Bomb with Mariana Budjeryn
Virtual Event
|
11AM EDT
Article
Ambassador Gustavo Zlauvinen
A Year of Unprecedented Urgency: Introducing the 2022 NTI Annual Report
Last year was full of extraordinary challenges to nuclear and biological security. From Russia’s unjustified invasion of Ukraine and nuclear threats to the ongoing devastation caused by the COVID-19 pandemic, the events of 2022 brought unparalleled urgency to NTI’s crucial mission.